Sulfadiazine silver chitinamine powder

A technology of silver sulfadiazine and silver chitosan, applied in skin diseases, antibacterial drugs, drug combinations, etc., can solve the problems of slow wound healing, poor stability and antibacterial efficacy, and achieves improved antibacterial efficacy and stability. , the effect of accelerating healing

Inactive Publication Date: 2003-04-16
陈延龙 +1
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The object of the present invention is to provide a kind of sulfadiazine silver chitosan powder, it can solve the problem that the existing technology has poor stability and antibacterial efficacy, and the healing speed of the wound is relatively slow

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Sulfadiazine silver chitosan powder, it comprises following component (by weight):

[0023] Sulfadiazine Silver 2Kg Chitosan 50Kg

[0024] Polyvinyl alcohol 150Kg

[0025] The above formula is micronized and pulverized by known technology, then mixed and packed into bags.

Embodiment 2

[0027] Described sulfadiazine silver chitosan powder, it comprises following component (by weight):

[0028] Sulfadiazine Silver 0.8Kg Chitosan 2Kg

[0029] Polyvinyl alcohol 70Kg

[0030] The above formula is micronized and pulverized by known technology, then mixed and packed into bags.

Embodiment 3

[0032] Described sulfadiazine silver chitosan powder, it comprises following component (by weight):

[0033] Silver sulfadiazine 1.2Kg Chitosan 10Kg

[0034] Polyvinyl alcohol 105Kg

[0035] The above formula is micronized and pulverized by known technology, then mixed and packed into bags.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A medicine "Sulfapyrimidine silver-crustamine" in the dosage form of powder contains sulfapyrimidine silver (0.5-2 wt. portions), crustamine (1-50) and polyvinyl alcohol (50-150). Its advantages are high stability and antibacterial effect, and high wound-healing speed.

Description

technical field [0001] The invention relates to the technical field of sulfadiazine-silver-chitosan composite medicine for external use. Background technique [0002] The raw material of sulfadiazine silver is white or off-white crystalline powder, which is easy to deteriorate when exposed to light or heat, and is insoluble in water, ethanol, chloroform or ether. Clinically, powder or ointment (cream) is often used as a treatment for burn wounds. It can not only inhibit wound infection, but also promote wound dryness, scab and healing, and has a significant curative effect. Silver sulfadiazine has a wide antibacterial spectrum, especially strong inhibitory effect on Pseudomonas aeruginosa, and has astringent effect. It is suitable for second or third degrees Burns are common in clinical applications. However, it has the disadvantages of poor stability and antibacterial efficacy, and slow wound healing. [0003] Clinical studies have shown that chitosan has a better effect...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/722A61P17/02A61P31/04
Inventor 陈延龙张瑞琛
Owner 陈延龙
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap